The Boeing Company (BA) Stock Analysis
Is BA a good investment?
The Boeing Company (BA) has a Plutrex AI rating of 47.0/100 as of November 03, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: PEG ratio of 0.29 vs. industry average 2.04 (85.8% discount) — Boeing projects next-year EPS growth of 176.5% (6x the 29.6% sector average) and 5-year EPS growth of 66.7% (3x the 21.99% sector norm), yet trades at a 34% PE discount to peers (19.32x vs. 29.29x); this growth-at-a-discount combination is the strongest valuation signal in the analysis. Main concern: FCF has dramatically worsened from -$210M (prior period) to -$1.543B currently — a 634% deterioration — meaning Boeing is consuming cash at an accelerating rate; combined with analysts slashing forecasts post-Q3 ('Boeing Analysts Slash Their Forecasts Following Q3 Results') and the analyst consensus target cut from $271.62 to $242.10, the recovery timeline is extending, not compressing, which is the key risk to the thesis.
Investment Summary
Boeing (BA) at $175.40 represents a deep-recovery story with compelling forward valuation metrics but severely impaired current fundamentals and a deteriorating near-term picture. The P/E has collapsed from 87.18x to 19.32x (a 77.8% drop), which sounds bullish but reflects downward earnings revisions rather than genuine multiple compression; the analyst consensus target has also been cut from $271.62 to $242.10 (-10.9%), signaling analyst confidence erosion. On the positive side, the PEG of 0.29 (vs. industry 2.04) remains the strongest valuation signal — the stock is priced at roughly one-seventh the growth-adjusted valuation of peers. However, the stock has fallen 8.4% since our last report (from $191.42 to $175.40), analysts have slashed forecasts post-Q3, and revenue growth has decelerated from 8.0% to 3.9%. Operating margin of 0.3% (vs. 11.33% industry average), gross margin of 9.44% (vs. 19.63% peers), D/E of 6.32 (vs. 0.518 industry), and negative FCF of -$1.543B collectively describe a company still in financial rehabilitation. News sentiment is balanced but leans negative, with headline 'Boeing Analysts Slash Their Forecasts Following Q3 Results' and 'Boeing Craters Again, Falling Beyond 20% Year-to-Date' confirming near-term headwinds. The $745B backlog is a genuine long-term anchor. Hold — the thesis remains intact but entry should wait for a better risk/reward setup.
Key Strengths
- PEG ratio of 0.29 vs. industry average 2.04 (85.8% discount) — Boeing projects next-year EPS growth of 176.5% (6x the 29.6% sector average) and 5-year EPS growth of 66.7% (3x the 21.99% sector norm), yet trades at a 34% PE discount to peers (19.32x vs. 29.29x); this growth-at-a-discount combination is the strongest valuation signal in the analysis
- $745 billion backlog with structural demand that cannot be quickly fulfilled — headline 'Boeing Has a Record $745 Billion Backlog and Can't Build the Planes Fast Fast Enough' confirms the demand thesis is intact and order pull-forward dynamics from fuel cost pressures (CEO commentary on high oil boosting jet orders) provide additional top-line visibility over a multi-year horizon
- Cash position of $20.67B provides meaningful liquidity runway despite -$1.543B FCF burn, and analyst consensus target of $242.10 implies 38% upside from current $175.40 — broad institutional recognition that the recovery thesis remains structurally sound even as near-term estimates are cut
Key Concerns
- FCF has dramatically worsened from -$210M (prior period) to -$1.543B currently — a 634% deterioration — meaning Boeing is consuming cash at an accelerating rate; combined with analysts slashing forecasts post-Q3 ('Boeing Analysts Slash Their Forecasts Following Q3 Results') and the analyst consensus target cut from $271.62 to $242.10, the recovery timeline is extending, not compressing, which is the key risk to the thesis
- Stock has fallen 8.4% in 14 days (from $191.42 to $175.40) and is down 20%+ year-to-date ('Boeing Craters Again, Falling Beyond 20% Year-to-Date'), with technical momentum clearly negative; operating margin of 0.30% (97.4% below the 11.33% industry average) and gross margin of 9.44% (51.9% below the 19.63% industry average) confirm that the operational turnaround has not materialized in reported numbers, leaving the valuation thesis dependent entirely on future execution
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
Boeing's fundamentals remain deeply bifurcated. Profitability: Gross margin 9.44% (vs. industry 19.63% — 52% below peers), operating margin 0.30% (vs. 11.33% peers — near-zero, operationally breakeven), net margin 7.7% (vs. 8.63% peers — this gap is narrow only because non-operating income inflates bottom-line results; the 0.3% operating vs. 7.7% net disconnect signals earnings quality risk). ROE of 173.6% is a mathematical artifact of negative book equity — economically meaningless. Financial Health: Cash of $20.67B provides ~13-year runway at current -$1.543B FCF burn rate, but FCF has worsened significantly from -$210M in the prior period to -$1.543B now — a 634% deterioration that is the most alarming metric change in this cycle. D/E of 6.32 (vs. 0.518 industry = 1,120% above peers). Growth: Next-year EPS growth 176.5% (vs. 29.6% industry — 6x peers), 5-year EPS growth 66.7% (vs. 21.99% industry — 3x peers), but these are normalization recoveries from a deeply depressed base. Revenue growth 3.9% vs. industry average 92.3% — top-line is essentially flat, making the entire thesis dependent on margin expansion. Valuation: P/E 19.32x (vs. 29.29x industry — 34% discount), PEG 0.29 (vs. 2.04 industry — 85.8% discount), analyst target $242.10 implies 38% upside. The valuation metrics are attractive IF execution materializes, but the FCF deterioration introduces new risk to the timeline.
News Sentiment
Boeing finds itself at a critical crossroads, with Wall Street increasingly losing patience with the aerospace giant's prolonged recovery. The company's stock has cratered more than 20% year-to-date — a stark reminder that turning around one of America's most iconic manufacturers is proving far more difficult and time-consuming than investors had hoped. The trouble deepened after Boeing's Q3 results, which prompted analysts to slash their forecasts, with the average price target dropping roughly $30 from earlier estimates. The headline 'Boeing Analysts Slash Their Forecasts Following Q3 Results' captured the mood on Wall Street: this recovery is taking longer than expected. The neutral-to-negative tone across recent coverage reflects genuine uncertainty about when — or if — Boeing's production machine will return to full efficiency. Yet not everything is doom and gloom. Boeing's CEO made headlines by pointing out that high oil prices could actually accelerate jet orders, as airlines rush to replace fuel-guzzling older aircraft with Boeing's more efficient models. More importantly, Boeing sits on a staggering $745 billion order backlog — essentially a decade of work — and the real problem isn't demand, it's the inability to build planes fast enough to fulfill those orders. For everyday investors, the story is this: Boeing has the orders, has the cash ($20.67 billion), and has the products airlines want. But execution problems, mounting losses, and a weakening balance sheet mean the turnaround clock is ticking louder than ever. Patience is required — but so is a disciplined entry price.
Risk Assessment
Primary risks: (1) FCF deterioration from -$210M to -$1.543B signals execution slippage — if this trend continues, the $20.67B cash cushion erodes faster than modeled, potentially forcing dilutive equity issuance or debt refinancing at elevated rates; (2) Q3 results triggered analyst forecast cuts, and the consensus target has already been reduced 10.9% from $271.62 to $242.10 — further cuts remain possible if production ramp targets are missed; (3) Technical momentum is clearly negative with the stock down 20%+ YTD and falling — in a market with alternatives, catching a falling knife requires patience and a defined entry zone; (4) Geopolitical and defense budget risks could pressure the defense segment. Mitigation: $20.67B cash provides genuine runway, the $745B backlog is real and contractually binding, and the PEG of 0.29 builds in substantial margin of safety versus the growth trajectory. Position sizing at 2.5% limits portfolio damage if the thesis extends further. Stop at $150 (~9.6% below entry) reflects the technical support zone and limits loss to ~2.4% of portfolio at 2.5% position size.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is BA a halal stock?
No, The Boeing Company (BA) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for BA?
The Boeing Company (BA) has a Plutrex AI rating of 47.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is BA a good investment?
According to Plutrex AI, BA has a Hold rating (47.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in BA?
US stocks like BA can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in BA?
Plutrex AI identifies the main risks for BA by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.